A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents: A 187 clinical laboratory center sample in the United States

Diagnostic Microbiology and Infectious Disease

Volumn 27, Issue 3, 1997, Pages 75-83

  Jones, Ronald N ^a   Jacobs, Michael R ^b   Washington, John A ^c   Pfaller, Michael A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CLARITHROMYCIN; LORACARBEF; MACROLIDE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CLINICAL TRIAL; FEMALE; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; STRAIN DIFFERENCE; UNITED STATES;

ADULT; AGE FACTORS; AGED; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SEX FACTORS; UNITED STATES;

EID: 0030983462     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00219-2     Document Type: Article

References (23)

1. Barry AL, Pfaller MA, Fuchs PC, Packer RR (1994) In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother 38:2419-2425.
2. Berk SL, Niederman MS, Segreti J (1994) Respiratory pathogens: Something old, something new. Patient Care 28:65-68.
3. Centers for Disease Control (1995) Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1993-1994. Morb Mort Weekly Rept 44:545-550.
4. deGroot R, Dzoljic-Danilovic G, vanKlingeren B, Goessens WHF, Neyens HJ (1991) Antibiotic resistance in Haemophilus influenzae: Mechanisms, clinical importance and consequences for therapy. Eur J Pediatr 150:534-546.
5. Doern GV (1995) Resistance among problem respiratory pathogens in pediatrics. Pediatr Infect Dis J 14:420-423.
6. Doern GV, Brueggemann A, Holley Jr. HP, Rauch AM (1996) Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother 40:1208-1213.
7. Doern GV, Jorgensen JH, Thornsberry C, Preston DA, and the Haemophilus influenzae Surveillance Group (1986) Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: A collaborative study. Diagn Microbiol Infect Dis 4:95-107.
8. Doern GV, Jorgensen JH, Thornsberry C, Preston DA, Tubert T, Redding JS, Maher LA (1988) National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother 32:180-185.
9. Fernandez-Roblas R, Lopez JC, Ramos JM, Gimeno M, Coronel P, Soriano F (1996) In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. J Antimicrob Chemother 37:1037-1039.
10. Georgiou M, Munoz R, Roman F, Canton R, Gomez-Lus R, Campos J, De La Campa A (1996) Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother 40:1741-1744.
11. Jacobs MR, Bajaksauzlan S (1997) Microbiologic evaluation of contemporary H. influenzae isolates having elevated MICs to amoxicillin/clavulanic acid. Diagn Microbiol Infect Dis (in press).
12. Jordens JZ, Slack MPE (1995) Haemophilus influenzae: Then and now. Eur J Clin Microbiol Infect Dis 14:935-948.
13. Jorgensen JH (1992) Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 14:1119-1123.
14. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS (1990) Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 34:2075-2080.
15. National Committee for Clinical Laboratory Standards (NCCLS) (1993) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A3. Villanova, PA: NCCLS.
16. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Performance standards for antimicrobial susceptibility testing. Sixth informational supplement M100-S6. Villanova, PA: NCCLS.
17. Needham CA (1988) Haemophilus influenzae: Antibiotic susceptibility. Clin Microbiol Rev 1:218-227.
18. Pfaller MA, Hollis RJ, Sader HS (1992) PFGE analysis of chromosomal restriction fragments. In: Clinical Microbiology Procedures Handbook, vol. 2, Ed, HD Isenberg. Washington DC: American Society for Microbiology, p. 10.5.c.1-10.5.c.12.
19. Rittenhouse SF, Miller L, Kaplan RL, Mosely GH, Poupard JA (1995) A survey of β-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates. Diagn Microbiol Infect Dis 21:223-225.
20. Sutton LD, Biedenbach DJ, Yen A, Jones RN (1995) Development, characterization, and initial evaluations of S1. A new chromogenic cephalosporin for β-lactamase detection. Diagn Microbiol Infect Dis 21:1-8.
21. Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, the Haemophilus influenzae Study Group (1996) Invasive disease due to Haemophilus influenzae serotype f: Clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. Clin Infect Dis 22:1069-1076.
22. Venkatesan P, Innes JA (1995) Antibiotic resistance in respiratory pathogens. Thorax 50:481-483.
23. Ward JI (1996) Editorial response: Invasive infections due to Haemophilus influenzae serotype f (Hif). Is Hif an emerging pathogen? Clin Infect Dis 22:1077-1078.